U.S. markets closed

Alimera Sciences, Inc. (ALIM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.99-0.31 (-3.01%)
At close: 4:00PM EDT
9.96 -0.03 (-0.30%)
After hours: 05:58PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close10.30
Open10.26
Bid9.79 x 800
Ask9.96 x 800
Day's Range9.99 - 10.26
52 Week Range3.82 - 12.25
Volume10,268
Avg. Volume44,565
Market Cap69.085M
Beta (5Y Monthly)1.86
PE Ratio (TTM)N/A
EPS (TTM)-1.47
Earnings DateJul 27, 2021 - Aug 02, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est16.38
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Investors Who Bought Alimera Sciences (NASDAQ:ALIM) Shares A Year Ago Are Now Up 104%
    Simply Wall St.

    Investors Who Bought Alimera Sciences (NASDAQ:ALIM) Shares A Year Ago Are Now Up 104%

    When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right...

  • ACCESSWIRE

    35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021

    RALEIGH, NC / ACCESSWIRE / May 27, 2021 / The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.The Summer Solstice - Best Ideas from the Buy Side: VIRTUAL begins on Tuesday, June 1, 2021, with company presentations beginning at 9am Eastern Time.

  • Alimera Sciences, Inc. to Present at the Summer Solstice – Best Ideas from the Buy Side Conference on June 2, 2021
    GlobeNewswire

    Alimera Sciences, Inc. to Present at the Summer Solstice – Best Ideas from the Buy Side Conference on June 2, 2021

    ATLANTA, May 27, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that management has been invited to present at the Summer Solstice - Best Ideas from the Buy Side Conference, which is being held virtually on June 1 – June 4, 2021. Rick Eiswirth, President and Chief Executive Officer will deliver his corporate presentation on June 2, 2021 at 10:30am ET. The presentation will be webcast live and available for replay at https://www.webcaster4.com/Webcast/Page/2134/41505 To receive additional information, request an invitation, please email angie.goertz@issuerdirect.com. Investors can register here. About the MicroCap Rodeo Summer Solstice Best Ideas Conference The MicroCap Rodeo is back with its third "Best Ideas Bowl." This conference is a virtual conference that brings you the top 35 best ideas from the buy side. Qualified institutional investors recommended each of the 35 companies represented as one of their best ideas. Those of you who attended the 2019 MicroCap Rodeo in Austin, Texas, know that we're focused on alpha. About Alimera Sciences, Inc. Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people in our aging populations. For more information, please visit www.alimerasciences.com. For press inquiries:Jules Abrahamfor Alimera Sciences917-885-7378julesa@coreir.comFor investor inquiries:Scott Gordonfor Alimera Sciencesscottg@coreir.com